Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.


Player Avatar jjayzzone (< 20) Submitted: 5/12/2008 4:50:06 PM : Outperform Start Price: $25.49 FMS Score: -7.50

My company is working on the expansion of the Fresenius site in Ogden, Utah. In the simplest terms, there are now six lines producing the "fibers" used in the dialysis equipment. There are more lines to come, oh yes, there are more....which means there will be more production. This company is only growing, and I know this from first hand experience.

Featured Broker Partners